EDP Biotech is an in-vitro diagnostic company and CLIA laboratory developing tests that detect disease early. Our platform utilizes machine learning and multiplexing which allows looking at up to 50 proteins from a single blood draw. EDP plans to leverage its technology through strategic partnerships in the near term, followed by launching its first multi-marker test from the platform, ColoPlex™, used in the early detection of colorectal cancer.